medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2007, Number 4

<< Back Next >>

Arch Neurocien 2007; 12 (4)

Eficiency of electroconvulsive therapy in Parkinson disease experience at the neurological Institute

Nente CFA, Campillo SC, Sosa OAL

Language: Spanish
References: 41
Page: 212-220
PDF size: 73.03 Kb.


ABSTRACT

The study was done to find the eficiency of electroconvulsive therapy in idiopatic Parkinson. We evaluated 7 patients and before the therapy their motor capacity was evaluated and after they recive 10 sesions of electro therapy were followed at 2 and 24 months a marked reduction of extrapiramidal symptoms, and psiquiatric ones were improved howenuer 4 months latter a lost of the knotor improvement was observed. We belive that further study is necessary.


REFERENCES

  1. Bennett DA, Beckett LA, Murray AM. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996;334:71-6

  2. Lilienfeld DE, Perl DP. Projected neurodegenerative disease mortality in the United States, 1990-2040. Neuroepidemiology 1993;12:219-28.

  3. Lauterbach Edward C. The neuropsychiatry of Palkinson’s disease and related disorders. Psychiatr Clin N Am 2004;27:801-25.

  4. Hughes PJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson’s disease. Arch Neurol 1993;50:140-8.

  5. Merello M, Nouzeilles MI, Arce GP, Leiguarda R. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a mayor criterion for Idiopathic Parkinson’s disease diagnosis, Movement Disorders 2002;17:795-8.

  6. Micheli F. Enfermedad de Parkinson. En: Micheli F; Nogués MA; Asconapé JJ; Fernández MM; Biller J (Eds). Tratado de Neurología Clínica. Ed. Panamericana. 2002.

  7. Louis ED, Tang MX. Progression of Parkinsonian signs in Parkinson’s disease. Arch Neurol 1999; 56: 334-7.

  8. Glosser G. Neurobehavioral aspects of movement disorders. Neurologic Clinics 2001; 19 (3): 535-51.

  9. Green J, McDonald WM. Cognitive impairments in advanced PD without dementia. Neurology 2002; 59: 1324-29.

  10. DSM-IV. Guía de uso. Edit. Masson. 1997.

  11. Sebastian E Noé, Sieira P Irimia, Arias EM Pomares. Neuropsychiatric disorders in Parkinson’s disease. Rev Neurol 2001;32:676- 81.

  12. Siemers ER, Shekhar A, Quaid K. Anxiety and motor performance in Parkinson’ s disease. Mov Disord 1993;8:501-6.

  13. Trenkw Alder C. Sleep dysfunction in Parkinson’s disease. Clin Neurosci 1998;5: 107-14.

  14. Calne DB. Drug Therapy: treatment of Parkinson’s disease. N Engl J Med 1993;329(14): 1021-7.

  15. Cerletti Ugo, Stefano Pallanti. Am J Psychiatry 1999;156:4.

  16. Coffey Edward. The clinical science of electroconvulsive Therapy. American Psychiatric Press Inc. Washington 1993.

  17. Séller Charles. Electroconvulsive therapy. The Psychiatric Clinics of North America. 1991.

  18. American Psychiatric Association: The practice of ETC: recommendations for practice, training and privileging. Task force report on ETC. Washington, DC, American Psychiatric Press, 1990.

  19. American Psychiatric Association: The practice of electroconvulsive therapy. Recommendations for treatment, training, and privileging. Washington, DC, American Psychiatric Association 2001.

  20. Royal College of Psychia Trists, Memorandum on the use of ETC. Br J Psychiatry 1997;131:261-72.

  21. Adaglio M, Ghini V, Rodríguez A. Terapia electroconvulsiva. Alcmeon 1998; (26)1998; 7-7.

  22. Royal College of Psychiatrists. The practical administration of ETC. London, Royal College of Psychiatrists, 1989.

  23. Fabér R, Audie L, Electroconvulsive therapy in Parkinson’s disease. JECT 2001; 17(1): 78.

  24. Kennedy Richard, Dinesh Mittal, Judith Ouile. J Neuropsychiatry Clin Neurosci 2003; 15:4.

  25. Rummans OH J, O’Connor Mk. Cognitive impairment after ECT in patients with Parkinson’s disease and psychiatric illness (letter). Am J Psychiatry 1992; 149:271.

  26. Faber R, Trimble M. Electroconvulsive therapy Parkinson’s disease and other movement disorders. Mov Disord 1991; 6:293-303.

  27. Pridmore S, Pollard C. Electroconvulsive therapy in Parkinson’s disease: 30-month followup. J Neurol Neurosurg Psychiatry 1996; 61:693-700.

  28. Moellentine E, Rummans T, Ahlskog JE, Harmsen WS, Suman VJ, O’Connor MK, et al. Effectiveness of ECT in patients with parkinsonism. J Neuropsychiatry Clin Neurosci 1998; 10(2): 187-93.

  29. Fochtmann LA. Mechanism for the efficacy of ECT in Parkinson’s disease convulsive ther 1988;4: 321-7.

  30. Sandyk R. Mechanisms of action in Parkinson’ s disease: posible role of pineal melatonin. Int J Neurosci 1990; 50(1-2):83-94.

  31. Ruiz Chow Angel Alberto. Tratamiento coadyuvante de terapia eléctrica en la enfermedad de Parkinson idiopatica. Tesis. Universidad Nacional Autonoma de México Facultad de Medicina 2003.

  32. Kamat Sanjeev M, Philip J Lefevre, George T. Grossberg. Clin Geriatr Med 2003; 19:825-39 Electroconvulsive therapy in the elderly.

  33. Corona T, Rivera C, Otero E, Stopp L. A longitudinal study of the effects of an L-dopa drug holiday on the course of Parkinson’s disease. Clin Neuropharmacol 1975; 18(.1):325-32.

  34. Folstein MF, Folstein SE, Mchugh PR. Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-98.

  35. Ventura MA, Green MF, Shaner A, Liberman RP. Training and quality assurance with the briefpsychiatric rating scale: “The drift buster”. Inter J Methods Psychiatric Res 1993; 3:221-44.

  36. Bech Alec Coppen. ECNP. Congress The Hamilton scales es Berlín. New York: SpringerVerlag, 1990.

  37. Kiernanrj Mueller K, Langston Jw, Van Dyke C. Neurobehavioral cognitive status examination [NCSE or COGNISTAT] 1987.

  38. Movement Disorder Society. Task force on rating scales for Parkinson’s disease. The unified Parkinson’s disease rating scale (UPDRS): status and recommendations. Mov Disord 2003; 18:738-50.

  39. Schwab RS, England AC JR. Projection techniques for evaluating surgery in Parkinson’s Disease. Third Symposium on Parkinson’s Disease, Royal College of Surgeons in Edinburgh, May 20-22, 1968. E. & S. Livingstone Ltd. 1969.

  40. Hoehn MM. AHR Unified Parkinson’s disease rating scale [UPDRS]: modified Hoehn and Yahr staging. En. Herndon RM, Handbook of Clinical Neurologic Scales. New York: Demos Vennande. 1997.

  41. Swatz CM, Abrams R. Prolation levels after bilateral and unilateral ECT. Br J Psychiatry 1984; 144:643-5.




2020     |     www.medigraphic.com